Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)
China
· Delayed Price · Currency is CNY 28.90
-0.52 (-1.77%)
Jun 17, 2025, 2:45 PM CST
SHA:688393 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 2.24 | 21.29 | 40.06 | 42.69 | 79.78 | 84.75 | Upgrade
|
| Depreciation & Amortization | 39.7 | 39.7 | 40.99 | 35.69 | 18.58 | 10.46 | Upgrade
|
| Other Amortization | 6.77 | 6.77 | 6.02 | 4 | 3.34 | 1.18 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.33 | -0.33 | -0.36 | 0.02 | -0.31 | 0.13 | Upgrade
|
| Asset Writedown & Restructuring Costs | 3.85 | 3.85 | 4.06 | 0.12 | 0.93 | 0.43 | Upgrade
|
| Loss (Gain) From Sale of Investments | -5.35 | -5.35 | -5.14 | 3.14 | -12.86 | -4.53 | Upgrade
|
| Provision & Write-off of Bad Debts | 5.67 | 5.67 | 4.5 | 5.35 | 1.69 | 6.02 | Upgrade
|
| Other Operating Activities | 37.52 | -9.9 | -22.24 | -11.39 | -2.68 | -1.05 | Upgrade
|
| Change in Accounts Receivable | -7.45 | -7.45 | -9.29 | -36.17 | -35 | -20.14 | Upgrade
|
| Change in Inventory | -30.23 | -30.23 | -30.49 | -23.07 | -16.65 | -13.8 | Upgrade
|
| Change in Accounts Payable | -5.41 | -5.41 | -6.17 | -7.04 | 17.02 | 26.68 | Upgrade
|
| Change in Other Net Operating Assets | -6.43 | -6.43 | 5.83 | - | - | - | Upgrade
|
| Operating Cash Flow | 31.91 | 3.54 | 17.12 | 9.72 | 59.61 | 91.43 | Upgrade
|
| Operating Cash Flow Growth | 200.88% | -79.31% | 76.21% | -83.70% | -34.80% | 1.88% | Upgrade
|
| Capital Expenditures | -11.74 | -23.65 | -37.74 | -72.17 | -143.34 | -62.45 | Upgrade
|
| Sale of Property, Plant & Equipment | -0.44 | 0.03 | 2.93 | 2.2 | 2.93 | 0.19 | Upgrade
|
| Cash Acquisitions | - | - | -1.25 | - | -31.85 | - | Upgrade
|
| Investment in Securities | -6.74 | 77.22 | 0.9 | -52.33 | -281.67 | -125.8 | Upgrade
|
| Other Investing Activities | 6.87 | 3.51 | 2.47 | 7.37 | 7.32 | 4.75 | Upgrade
|
| Investing Cash Flow | -12.05 | 57.12 | -32.7 | -114.92 | -446.61 | -183.31 | Upgrade
|
| Short-Term Debt Issued | - | 7.3 | 21.2 | 14.3 | 7 | - | Upgrade
|
| Total Debt Issued | 7.3 | 7.3 | 21.2 | 14.3 | 7 | - | Upgrade
|
| Short-Term Debt Repaid | - | -21.2 | -14.3 | -7 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -2.14 | -2.51 | -2.67 | -2.53 | - | Upgrade
|
| Total Debt Repaid | -8.49 | -23.34 | -16.81 | -9.67 | -2.53 | - | Upgrade
|
| Net Debt Issued (Repaid) | -1.19 | -16.04 | 4.39 | 4.63 | 4.47 | - | Upgrade
|
| Issuance of Common Stock | - | - | 2.18 | - | - | - | Upgrade
|
| Common Dividends Paid | -14.49 | -14.51 | -13.47 | -26.61 | -26.33 | - | Upgrade
|
| Other Financing Activities | -4.27 | -4.17 | - | 0.58 | -7.67 | 639.33 | Upgrade
|
| Financing Cash Flow | -19.95 | -34.72 | -6.89 | -21.4 | -29.53 | 639.33 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.17 | -0.12 | 0.08 | 0.14 | -0.06 | -0.1 | Upgrade
|
| Net Cash Flow | -0.26 | 25.82 | -22.39 | -126.46 | -416.58 | 547.35 | Upgrade
|
| Free Cash Flow | 20.17 | -20.1 | -20.62 | -62.45 | -83.73 | 28.98 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | -46.53% | Upgrade
|
| Free Cash Flow Margin | 4.57% | -4.27% | -4.15% | -12.31% | -19.07% | 7.72% | Upgrade
|
| Free Cash Flow Per Share | 0.22 | -0.22 | -0.22 | -0.66 | -0.89 | 0.37 | Upgrade
|
| Cash Income Tax Paid | 28.83 | 31.1 | 27.31 | 23.13 | 17.02 | 32.34 | Upgrade
|
| Levered Free Cash Flow | -115.6 | -91.53 | -108.95 | -69.45 | -122.56 | 5.74 | Upgrade
|
| Unlevered Free Cash Flow | -115.17 | -91.12 | -108.45 | -68.6 | -122.32 | 5.74 | Upgrade
|
| Change in Net Working Capital | 131.39 | 105.86 | 128.26 | 57.15 | 45.01 | -7.87 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.